Circulating Tumor Cells in Breast Cancer Patients: An Evolving Role in Patient Prognosis and Disease Progression

Wang, Y. W., Zhao, S., Zhang, K., Zhu, J., Liu, Y., Wang, J., & Ma, R. (2018). Tumor Biomarkers in Nipple Discharge of Breast Cancer: Current Status and Future Perspectives. Adaptive Medicine, 10(2), 59-63. https://doi.org/10.4247/AM.2018.ABI206
Dechaphunkul, A., Phukaoloun, M., Kanjanapradit, K., Graham, K., Ghosh, S., Santos, C., & Mackey, J. R. (2012). Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 in Breast Cancer. International Journal of Breast Cancer, 2012(), 78-87. https://doi.org/10.1155/2012/290854
Yang, C. Y. (2020). Proteomic profiling and mechanistic studies of breast cancer derived exosomes during tumor progression [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202100159
Kittaneh, M., Montero, A. J., & Glück, S. (2013). Molecular Profiling for Breast Cancer: A Comprehensive Review. Biomarkers in Cancer, 2013(), 61-70. https://doi.org/10.4137/BIC.S9455
王董華（2019）。Long-term Outcomes and Predictors for response of Breast Cancer following Neoadjuvant Chemotherapy〔碩士論文，義守大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0074-2907201900252500